A novel immune-related genes signature after bariatric surgery is histologically associated with non-alcoholic fatty liver disease

References

• NCD-RisC. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–2642. London, England.
   PubMed Web of Science ®Google Scholar
• Huh YJ, Seo JY, Nam J, et al. Bariatric/metabolic surgery induces noticeable changes of microbiota and their secreting extracellular vesicle composition in the gut. Obes Surg. 2019;29(8):2470–2484.
   PubMed Web of Science ®Google Scholar
• Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766–781. London, England.
   PubMed Web of Science ®Google Scholar
• Haas JT, Vonghia L, Mogilenko DA, et al. Transcriptional Network Analysis Implicates Altered Hepatic immune function in NASH development and resolution. Nat Metab. 2019;1(6):604–614.
   PubMedGoogle Scholar
• Brunt EM. Pathology of nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol. 2010;7(4):195–203.
   Google Scholar
• Goossens N, Hoshida Y, Song WM, et al. Nonalcoholic steatohepatitis is associated with increased mortality in obese patients undergoing bariatric surgery. Clin Gastroenterol Hepatol. 2016;14(11):1619–1628.
   PubMed Web of Science ®Google Scholar
• Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Clin Pract Gastroenterol Hepatol. 2018;15(1):11–20.
   Google Scholar
• Mathis D. Immunological goings-on in visceral adipose tissue. Cell Metab. 2013;17(6):851–859.
   PubMed Web of Science ®Google Scholar
• Stanton MC, Chen SC, Jackson JV, et al. Inflammatory signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice. J Inflam. 2011;8(1):8. London, England.
   Google Scholar
• Poitou C, Perret C, Mathieu F, et al. Bariatric surgery induces disruption in inflammatory signaling pathways mediated by immune cells in adipose tissue: a RNA-Seq study. PloS One. 2015;10(5):e0125718.
   PubMed Web of Science ®Google Scholar
• Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes–3-year outcomes. N Engl J Med. 2014;370(21):2002–2013.
   PubMed Web of Science ®Google Scholar
• Chen Y, Yang J, Nie X, et al. Effects of bariatric surgery on change of brown adipocyte tissue and energy metabolism in obese mice. Obes Surg. 2018;28(3):820–830.
   PubMed Web of Science ®Google Scholar
• Liu Y, Jin J, Chen Y, et al. Integrative analyses of biomarkers and pathways for adipose tissue after bariatric surgery. Adipocyte. 2020;9(1):384–400.
   PubMed Web of Science ®Google Scholar
• Laursen TL, Hagemann CA, Wei C, et al. Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects. World J Hepatol. 2019;11(2):138–149.
   PubMed Web of Science ®Google Scholar
• Guo D, Wang M, Shen Z, et al. A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma. J Transl Med. 2020;18(1):123.
   PubMed Web of Science ®Google Scholar
• Zhu R, Tao H, Lin W, et al. Identification of an immune-related gene signature based on immunogenomic landscape analysis to predict the prognosis of adult acute myeloid leukemia patients. Front Oncol. 2020;10:574939.
   PubMed Web of Science ®Google Scholar
• Petrus P, Mejhert N, Corrales P, et al. Transforming growth factor-β3 regulates adipocyte number in subcutaneous white adipose tissue. Cell Rep. 2018;25(3):551–60.e5.
   PubMed Web of Science ®Google Scholar
• Hoggard N, Cruickshank M, Moar KM, et al. Using gene expression to predict differences in the secretome of human omental vs. subcutaneous adipose tissue. Obesity. 2012;20(6): 1158–1167. Silver Spring, Md.
   PubMed Web of Science ®Google Scholar
• Lefebvre P, Lalloyer F, Baugé E, et al. Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin. JCI Insight. 2017;2(13):13.
   Web of Science ®Google Scholar
• Du Plessis J, Van Pelt J, Korf H, et al. Association of adipose tissue inflammation with histologic severity of nonalcoholic fatty liver disease. Gastroenterology. 2015;149(3):635–48.e14.
   PubMed Web of Science ®Google Scholar
• Ahrens M, Ammerpohl O, von Schönfels W, et al. DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. Cell Metab. 2013;18(2):296–302.
   PubMed Web of Science ®Google Scholar
• Jia X, Zhai T. Integrated analysis of multiple microarray studies to identify novel gene signatures in non-alcoholic fatty liver disease. Front Endocrinol (Lausanne). 2019;10:599.
   PubMed Web of Science ®Google Scholar
• Wilson PC, Wu H, Kirita Y, et al. The single-cell transcriptomic landscape of early human diabetic nephropathy. Proc Natl Acad Sci U S A. 2019;116(39):19619–19625.
   PubMed Web of Science ®Google Scholar
• Chin CH, Chen SH, Wu HH, et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11.
   PubMed Web of Science ®Google Scholar
• Newman AM, Steen CB, Liu CL, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773–782.
   PubMed Web of Science ®Google Scholar
• Rogero MM, Calder PC. Obesity, inflammation, toll-like receptor 4 and fatty acids. Nutrients. 2018;10(4):4.
   Web of Science ®Google Scholar
• Kolb R, Sutterwala FS, Zhang W. Obesity and cancer: inflammation bridges the two. Curr Opin Pharmacol. 2016;29:77–89.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang J, Liu Z, et al. More than an anti-diabetic bariatric surgery, metabolic surgery alleviates systemic and local inflammation in obesity. Obes Surg. 2018;28(11):3658–3668.
   PubMed Web of Science ®Google Scholar
• Lee BC, Lee J. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta. 2014;1842(3):446–462.
   PubMed Web of Science ®Google Scholar
• Saad ZA, Khodeer DM, Zaitone SA, et al. Exenatide ameliorates experimental non-alcoholic fatty liver in rats via suppression of toll-like receptor 4/NFκB signaling: comparison to metformin. Life Sci. 2020;253:117725.
   PubMed Web of Science ®Google Scholar
• Wang J, Ma J, Nie H, et al. Hepatic regulator of G protein signaling 5 ameliorates nonalcoholic fatty liver disease by suppressing transforming growth factor beta-activated Kinase 1-c-Jun-N-Terminal Kinase/p38 signaling. Hepatology. 2021;73(1):104–125. Baltimore, Md.
   PubMed Web of Science ®Google Scholar
• Cuff AO, Sillito F, Dertschnig S, et al. The obese liver environment mediates conversion of NK cells to a less cytotoxic ILC1-Like phenotype. Front Immunol. 2019;10:2180.
   PubMed Web of Science ®Google Scholar
• Roh YS, Seki E. Chemokines and chemokine receptors in the development of NAFLD. Adv Exp Med Biol. 2018;1061:45–53.
   PubMed Web of Science ®Google Scholar
• Dodington DW, Desai HR, Woo M. JAK/STAT - emerging players in metabolism. Trends Endocrinol Metab. 2018;29(1):55–65.
   PubMed Web of Science ®Google Scholar
• Mishra J, Verma RK, Alpini G, et al. Role of janus kinase 3 in predisposition to obesity-associated metabolic syndrome. J Biol Chem. 2015;290(49):29301–29312.
   PubMed Web of Science ®Google Scholar
• INVALID CITATION.
   Google Scholar
• Kurniawan DW, Jajoriya AK, Dhawan G, et al. Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis. J Control Release. 2018;288:227–238.
   PubMed Web of Science ®Google Scholar
• Dai W, Sun Y, Jiang Z, et al. Key genes associated with non-alcoholic fatty liver disease and acute myocardial infarction. Med Sci Monit. 2020;26:e922492.
   PubMed Web of Science ®Google Scholar
• Adam S, Liu Y, Siahmansur T, et al. Bariatric surgery as a model to explore the basis and consequences of the reaven hypothesis: small, dense low-density lipoprotein and interleukin-6. Diab Vasc Dis Res. 2019;16(2):144–152.
   PubMed Web of Science ®Google Scholar
• Modolin MLA, Cintra W Jr., Rocha RI, et al. Analysis of inflammatory and metabolic biomarkers in patients submitted to abdominoplasty after bariatric surgery. Acta Cir Bras. 2019;34(5):e201900506.
   PubMed Web of Science ®Google Scholar
• Sala P, Torrinhas R, Fonseca DC, et al. Intestinal expression of toll-like receptor gene changes early after gastric bypass surgery and association with type 2 diabetes remission. Nutrition. Burbank, Los Angeles County, Calif 2020;79-80: 110885.
   PubMed Web of Science ®Google Scholar
• Wu L, Sun J, Liu L, et al. Anti-toll-like receptor 2 antibody ameliorates hepatic injury, inflammation, fibrosis and steatosis in obesity-related metabolic disorder rats via regulating MAPK and NF-κB pathways. Int Immunopharmacol. 2020;82:106368.
   PubMed Web of Science ®Google Scholar
• Chen F, Zhou Y, Wu Z, et al. Integrated analysis of key genes and pathways involved in nonalcoholic steatohepatitis improvement after roux-en-Y gastric bypass surgery. Front Endocrinol (Lausanne). 2020;11:611213.
   PubMed Web of Science ®Google Scholar
• Boujedidi H, Robert O, Bignon A, et al. CXCR4 dysfunction in non-alcoholic steatohepatitis in mice and patients. Clin Sci. 2015;128(4):257–267. London, England: 1979.
   Web of Science ®Google Scholar
• van Beek L, Vroegrijk IO, Katiraei S, et al. FcRγ-chain deficiency reduces the development of diet-induced obesity. Obesity (Silver Spring, Md). 2015;23(12):2435–2444.
   PubMed Web of Science ®Google Scholar
• Hao JW, Wang J, Guo H, et al. CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis. Nat Commun. 2020;11(1):4765.
   PubMed Web of Science ®Google Scholar
• Lassailly G, Caiazzo R, Buob D, et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology. 2015;149(2):379–388.
   PubMed Web of Science ®Google Scholar
• Braunersreuther V, Viviani GL, Mach F, et al. Role of cytokines and chemokines in non-alcoholic fatty liver disease. World J Gastroenterol. 2012;18(8):727–735.
   PubMed Web of Science ®Google Scholar
• Maurizi G, Della Guardia L, Maurizi A, et al. Adipocytes properties and crosstalk with immune system in obesity-related inflammation. J Cell Physiol. 2018;233(1):88–97.
   PubMed Web of Science ®Google Scholar
• Russo L, Lumeng CN. Properties and functions of adipose tissue macrophages in obesity. Immunology. 2018;155(4):407–417.
   PubMed Web of Science ®Google Scholar
• Jalilvand A, Blaszczak A, Bradley D, et al. Low visceral adipose tissue regulatory T cells are associated with higher comorbidity severity in patients undergoing bariatric surgery. Surg Endosc. 2021;35(6):3131-8.
   Web of Science ®Google Scholar
• Vonghia L, Ruyssers N, Schrijvers D, et al. CD4+ROR γ t++ and tregs in a mouse model of diet-induced nonalcoholic steatohepatitis. Mediators Inflamm. 2015;2015:239623.
   Web of Science ®Google Scholar